No headlines found.
Globe Newswire (Thu, 26-Mar 4:05 PM ET)
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Arcadia Biosciences trades on the NASDAQ stock market under the symbol RKDA.
As of April 30, 2026, RKDA stock price declined to $1.05 with 23,083 million shares trading.
RKDA has a beta of 1.09, meaning it tends to be more sensitive to market movements. RKDA has a correlation of 0.03 to the broad based SPY ETF.
RKDA has a market cap of $2.16 million. This is considered a Sub-Micro Cap stock.
Last quarter Arcadia Biosciences reported $901,000 in Revenue and -$.97 earnings per share. This fell short of revenue expectation by $-499,000 and missed earnings estimates by -$.31.
In the last 3 years, RKDA traded as high as $10.31 and as low as $.89.
The top ETF exchange traded funds that RKDA belongs to (by Net Assets): VXF.
RKDA has underperformed the market in the last year with a price return of -68.5% while the SPY ETF gained +31.0%. RKDA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -50.0% and -24.5%, respectively, while the SPY returned +3.8% and +2.7%, respectively.
RKDA support price is $.98 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RKDA shares will trade within this expected range on the day.
